KLSE (MYR): DCHCARE (0283)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.205
Today's Change
0.00 (0.00%)
Day's Change
0.205 - 0.215
Trading Volume
5,653,100
Market Cap
204 Million
NOSH
996 Million
Latest Quarter
31-Mar-2024 [#1]
Announcement Date
27-May-2024
Next Quarter
30-Jun-2024
Est. Ann. Date
29-Aug-2024
Est. Ann. Due Date
29-Aug-2024
QoQ | YoY
-637.09% | -435.55%
Revenue | NP to SH
60,432.000 | -7,706.000
RPS | P/RPS
6.07 Cent | 3.38
EPS | P/E | EY
-0.77 Cent | -26.50 | -3.77%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.06 | 3.42
QoQ | YoY
-401.02% | -426.94%
NP Margin | ROE
-12.75% | -12.89%
F.Y. | Ann. Date
31-Mar-2024 | 27-May-2024
Latest Audited Result
31-Dec-2023
Announcement Date
30-Apr-2024
Next Audited Result
31-Dec-2024
Est. Ann. Date
30-Apr-2025
Est. Ann. Due Date
29-Jun-2025
Revenue | NP to SH
67,789.000 | 2,560.000
RPS | P/RPS
6.80 Cent | 3.01
EPS | P/E | EY
0.26 Cent | 79.78 | 1.25%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.06 | 3.42
YoY
null%
NP Margin | ROE
3.78% | 4.28%
F.Y. | Ann. Date
31-Dec-2023 | 27-Feb-2024
Revenue | NP to SH
37,816.000 | -31,636.000
RPS | P/RPS
3.80 Cent | 5.40
EPS | P/E | EY
-3.16 Cent | -6.46 | -15.49%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
-1335.78% | -435.55%
NP Margin | ROE
-83.66% | -52.92%
F.Y. | Ann. Date
31-Mar-2024 | 27-May-2024
Trailing 4 Quarters | Trailing 8 Quarters | |||
---|---|---|---|---|
Available Quarters | 4 Quarters | 8 Quarters | ||
Continuous Quarters Of Revenue Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Total Positive Profit Years | 1 / 4 | 25.00% | 2 / 8 | 25.00% |
Continuous Quarters Of Positive Profit | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Profit Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Adjusted EPS Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Total Dividend Years | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Dividend | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Dividend Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Adjusted Dps Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Average ROE | -0.54% | 1.58% | ||
Average Net Profit Margin | -21.25% | -8.87% |
Last 5 Financial Years | Last 10 Financial Years | |||
---|---|---|---|---|
Available Years | 5 Years | 10 Years | ||
Continuous Quarters Of Revenue Growth | 1 / 2 | 50.00% | 1 / 2 | 50.00% |
Total Positive Profit Years | 1 / 2 | 50.00% | 1 / 2 | 50.00% |
Continuous Quarters Of Positive Profit | 1 / 2 | 50.00% | 1 / 2 | 50.00% |
Continuous Quarters Of Profit Growth | 1 / 2 | 50.00% | 1 / 2 | 50.00% |
Continuous Quarters Of Adjusted EPS Growth | 1 / 2 | 50.00% | 1 / 2 | 50.00% |
Total Dividend Years | 0 / 2 | 0.00% | 0 / 2 | 0.00% |
Continuous Quarters Of Dividend | 0 / 2 | 0.00% | 0 / 2 | 0.00% |
Continuous Quarters Of Dividend Growth | 0 / 2 | 0.00% | 0 / 2 | 0.00% |
Continuous Quarters Of Adjusted Dps Growth | 0 / 2 | 0.00% | 0 / 2 | 0.00% |
Average ROE | 2.14% | 2.14% | ||
Average Net Profit Margin | 1.89% | 1.89% |
T4Q | Annualized | Annual (Unaudited) | Last 10 FY Average | Last 5 FY Average | |
---|---|---|---|---|---|
Revenue | 60,432 | 37,816 | 67,789 | 33,894 | 33,894 |
NP to SH | -7,706 | -31,636 | 2,560 | 1,280 | 1,280 |
Dividend | 0 | 0 | 0 | 0 | 0 |
Adjusted EPS | -0.77 | -3.16 | 0.26 | 0.13 | 0.13 |
Adjusted DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share
All figures in '000 unless specified.
EPS & DPS's figures in Cent.
LQ QoQ | LQ YoY | CQ YoY | LQ vs Average of T4Q | LQ vs Average of T8Q | |
---|---|---|---|---|---|
Revenue | -46.20% | -43.76% | -43.76% | -37.42% | -2.09% |
NP to Owner | -637.09% | -435.55% | -435.55% | -310.54% | -1,082.88% |
Dividend | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Adjusted EPS | -618.18% | -433.93% | -433.93% | -306.79% | -1,069.87% |
Adjusted DPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year
T4Q vs LFY | T4Q vs AL5FY | T4Q vs AL10FY | AQR vs LFY | AQR vs AL5FY | AQR vs AL10FY | LFY YoY | LFY vs AL5FY | LFY vs AL10FY | |
---|---|---|---|---|---|---|---|---|---|
Revenue | -10.85% | 78.29% | 78.29% | -44.22% | 11.57% | 11.57% | 0.00% | 100.00% | 100.00% |
NP to Owner | -401.02% | -702.03% | -702.03% | -1,335.78% | -2,571.56% | -2,571.56% | 0.00% | 100.00% | 100.00% |
Dividend | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Adjusted EPS | -396.15% | -692.31% | -692.31% | -1,315.38% | -2,530.77% | -2,530.77% | 0.00% | 100.00% | 100.00% |
Adjusted DPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year
Get ready for the rally when its Q1 results are announced. Capture the coming rally at current cheap prices 😉
5 days ago
Dr Chong become Dr Con, spending money on all useless acquisition and revenue drop by almost 50%, exit while its not too late
4 days ago
Ouch.... Thought it would be good ... let's see how it goes when the market is open later
4 days ago
I love Dr Chong, after TP , now when people sell off, then is my time to buy it back.
4 days ago
revenue was down 44% , "mainly due to the lower redemption rate in aesthetic services."
not sure what it means... totally unexpected
4 days ago
profit was expected to be lower because of the costs of new outlets and marketing cost. Anyway, revenue was down 44%, now that's a different story. It's horrible!
4 days ago
ipo prospectus shows past results were profitable. Now seems they face challenges in making profits after ipo....
4 days ago
The change of revenue recognition from 3 months to 12 months is simply a matter of time and a different point of view, as most of the stock will also not instantly reflect the result.
4 days ago
Seems like 0.22 is the bottom price.. 2nd half of the year business should slowly improve
4 days ago
They sell aesthetic products in packages. The low redemption rate indicates that people have purchased the packages but have not yet used them. They can only recognize revenue when the customer redeems the package.
4 days ago
@mudaBubu
then where do you check those un-recognize revenue in the report? if not hard convince us as the revenue slump 50%~ which is terrifying
4 days ago
@mudaBubu
is there a way to find out the amount of money customers brought in in the previous quarter (3 months):
amount of money customers brought in and redeemed
amount of money customers brought in and not yet redeemed
we can add these 2 figures to know the amount of money customers brought in
or is there any figure that will help us to know how much revenue (recognized and unrecognized) is generated in previous 3 months.
Thank you in advance!
4 days ago
why can't the company recognize the revenue from the product packages paid by the customers where the amount of money paid is not refundable?
4 days ago
It's due to Malaysian Financial Reporting Standards, fortunefire. Under this MFRS, revenue can only be recognized when clients redeem their services.
4 days ago
There is a blog explaining the unrecognized revenue
The Truth Behind DC Healthcare Results!!
https://klse.i3investor.com/web/blog/detail/faizaleyes/2024-05-27-story-h-160716431-The_Truth_Behind_DC_Healthcare_Results
Contract liabilities
There are 2 Contract liabilities figures in quarterly report. The figure 9,591(000) in the balance sheet as at 31.03.2024 must have included unrecognized revenue in the last quarter and also quarters before that.
as at 31.12.2023 3,709 (000)
as at 31.03.2024 9,591(000)
there is an increase of 5882 (000) from Q4FY2023 to Q1FY2024
This Contract liabilities figure of 5,882 (000) found in the cash flow statement for the first quarter ended 31.03.2024 is the unrecognized revenue generated in the last quarter ALONE.
for Q1FY2024:
total sales = revenue 9,454 (000) + Contract liabilities 5,882 (000) = 15336 (000)
not too bad. This figure is lower than last year Q1FY2023
for Q1FY2023
total sales = revenue 16,811 (000) + Contract liabilities 68 (000) = 16879 (000)
3 days ago
Then we can anticipate DCHCARE's financial performance will improve in the next quarter
3 days ago
dont be naive, such niche market hardly grow significant in 1 or 2 quarter. it take years and years to prove it.
better find something that more promising with history performance record
3 days ago
Facial and slim program like consumable item, you must go for treatment every month. I dont understand why the half of previous package buyer suddenly didn't turn out during the past quarter. One possible is DC doing buy one free one promotion pre-IPO, so the clients paid pre-IPO and thus now DC has higher liability. My wild guess.
3 days ago
Like my wife does not go after bought the package. Now needing Rm for more important essentials in life. My wife forfeit the package la. I think maybe that’s the reason why…
You connect the dots laaa
3 days ago
Time is getting tougher now. Rm is allocated for essential now. Non essential.. need to set aside for now. Haizzz
3 days ago
this aesthetic business is a very competitive industry. blame the mfrs for not recognizing the revenue? come on!
3 days ago
Higher contract liabilities from RM3.7 million to RM9.6 million is interesting, if I'm not wrong DCHCARE collects deposits from customer for the next 12 months' aesthetic services, from the initial 3 months. So the profits & revenue number are "interesting" right now.
3 days ago
DC Healthcare will remain committed to its core business and aims to capitalise on the growth in the medical aesthetic industry, by establishing new medical aesthetic clinics in the Southern and Northern regions
2 days ago
@xiaolongbao numbers are definitely interesting, I think price wont go below 10cents - 0.20 my pick up price
2 days ago
The company GP has been dropping from 60% in 23Q2 down to 40% in 23Q4.
Even if you add back the 6m contract liabilities into the 24Q1 revenue total around 15m. Then GP is only 6m, minus staff cost and administrative charges 9m, it still incurred 3m losses !!
Off course opening new outlets and marketing expenses increased and causes the loss. But whenever you open new outlet this expenses will be there and s that mean forever the company will not making any profit ?
2 days ago
As usual, Pre-IPO report is well made and designed to please investor when they show all slide PTT.
Old trick, never get old.
Those using Pre-IPO or IPO's 1st two QR to speculate company future growth 100% fool.🤣
2 days ago
Aesthetic services is a long-term profitable business. Give it time to perform and improve
2 days ago
You won;t buy? the one posting above you buy a lot .....
Posted by Hatiharihari > 2023-09-11 15:03 | Report Abuse
Got it today instead at 0.50. Ha. Hold for 1-2 years I think can get good returns
1 day ago
Operation cost should be lower after new shops are opened, i think low entry price is around 18-20cents
20 hours ago
very hard to go back 0.4x unless all the doctors OT 24 hrs to increase sales
20 hours ago
If 50% of the packages are redeemed then it might be good, finally can count as profit
20 hours ago
Nowadays people invest a lot of money in beauty and appearance. Especially people are influenced by Korean pop music ..
19 hours ago
fortunefire
so did the company utilize 70mil from the reserve to acquire the 2 small clinics?
1 week ago